GSWM
HCWB icon

Golden State Wealth Management’s HCW Biologics HCWB Stock Holding History

Golden State Wealth Management’s Portfolio HCWB Stock Details HCWB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.32K Hold
1,667
– – ﹤0.01% 1153
2026
Q1 		$3.6K Hold
1,667
– – ﹤0.01% 1270
2025
Q4 		$9.71K Hold
1,667
– – ﹤0.01% 1112
2025
Q3 		$37K Hold
1,667
– – ﹤0.01% 750
2025
Q2 		$39.6K Buy
+1,667
New +$72.8K ﹤0.01% 699

Other funds holding HCWB

VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Golden State Wealth Management's HCWB Position: Q2 2026 in Review

Golden State Wealth Management held its HCW Biologics (HCWB) position steady in Q2 2026 at 1,667 shares worth $8.32K. The position accounts for ﹤0.01% of the portfolio, ranked #1153.

Golden State Wealth Management first reported a position in HCWB in Q2 2025 and has held it in 5 quarters since. The position peaked at $39.6K in Q2 2025. 7 funds tracked by Wall St. Rank hold HCWB as of Q2 2026.

  • Golden State Wealth Management held 1,667 shares of HCW Biologics worth $8.32K as of Q2 2026.
  • Golden State Wealth Management left its HCW Biologics share count unchanged in Q2 2026.
  • HCW Biologics made up ﹤0.01% of Golden State Wealth Management's portfolio in Q2 2026, its #1153 holding.
  • Golden State Wealth Management first reported a position in HCW Biologics in Q2 2025 and has held it in 5 quarters since.
  • Golden State Wealth Management's HCW Biologics position peaked at $39.6K in Q2 2025.
  • 7 funds tracked by Wall St. Rank held HCW Biologics as of Q2 2026.

Based on Golden State Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.